Tilia Selldén

4PUBLICATIONS

11CO-AUTHORS

Haematological tumoursRheumatology and arthritis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 03, 2026

Cytokine-induced PD-L1 and PD-L2 expression is preserved but reverse signalling is altered in rheumatoid arthritis fibroblast-like synoviocytes.

|Aug 29, 2025

Association of Soluble Immune Checkpoint Molecules PD1 and 4-1BB With CTLA-4Ig Treatment Response in Early Rheumatoid Arthritis.

Tilia Selldén, Kristina Lend, Jon Lampa

|Aug 28, 2025

Low Th2 and high PD1+ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritis.

Tilia Selldén, Kerstin Andersson, Inger Gjertsson

|Mar 21, 2023

Radiographic airway abnormalities in untreated early rheumatoid arthritis are associated with peripheral neutrophil activation.

Tilia Selldén, Carina Kärrman Mårdh, Martin Joelsson

Pageof 1

Frequent Collaborators

3 joint publications

Anna-Carin Lundell

2 joint publications

Inger Gjertsson

2 joint publications

Anna Rudin

2 joint publications

Anna-Karin Hultgård Ekwall

2 joint publications

Kristina Lend

1 joint publications

Åse Johnsson

1 joint publications

Michael T Nurmohamed

1 joint publications

Bjorn Gudbjornsson

1 joint publications

Tillmann Uhlig

1 joint publications

Cristina Maglio

Frequent Collaborators

3 joint publications

Anna-Carin Lundell

2 joint publications

Inger Gjertsson

2 joint publications

Anna Rudin

2 joint publications

Anna-Karin Hultgård Ekwall